These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11573860)
1. Is more than one quinolone needed in clinical practice? Paladino JA Ann Pharmacother; 2001 Sep; 35(9):1085-95. PubMed ID: 11573860 [TBL] [Abstract][Full Text] [Related]
2. A critical review of the fluoroquinolones: focus on respiratory infections. Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ Drugs; 2002; 62(1):13-59. PubMed ID: 11790155 [TBL] [Abstract][Full Text] [Related]
3. Levofloxacin and sparfloxacin: new quinolone antibiotics. Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064 [TBL] [Abstract][Full Text] [Related]
4. Quinolone activity against anaerobes. Appelbaum PC Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708 [TBL] [Abstract][Full Text] [Related]
5. The fluoroquinolones. Walker RC Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871 [TBL] [Abstract][Full Text] [Related]
6. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
7. Overview of the fluoroquinolone antibiotics. Just PM Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356 [TBL] [Abstract][Full Text] [Related]
8. The role of the fluoroquinolones. Guay DR Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503 [TBL] [Abstract][Full Text] [Related]
9. Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpoint. Lode H Chemotherapy; 2001; 47 Suppl 3():24-31; discussion 44-8. PubMed ID: 11549786 [TBL] [Abstract][Full Text] [Related]
10. The safety profile of the fluoroquinolones. Bertino J; Fish D Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507 [TBL] [Abstract][Full Text] [Related]
11. Trovafloxacin: a new fluoroquinolone. Alghasham AA; Nahata MC Ann Pharmacother; 1999 Jan; 33(1):48-60. PubMed ID: 9972385 [TBL] [Abstract][Full Text] [Related]
12. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials. Symonds WT; Nix DE Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892 [TBL] [Abstract][Full Text] [Related]
13. New fluoroquinolone antibiotics. Drug Ther Bull; 1999 Jan; 37(1):6-8. PubMed ID: 10562769 [TBL] [Abstract][Full Text] [Related]
14. Clinical use of fluoroquinolones in children. Alghasham AA; Nahata MC Ann Pharmacother; 2000 Mar; 34(3):347-59; quiz 413-4. PubMed ID: 10917383 [TBL] [Abstract][Full Text] [Related]
16. The new fluoroquinolones: A critical review. Zhanel GG; Walkty A; Vercaigne L; Karlowsky JA; Embil J; Gin AS; Hoban DJ Can J Infect Dis; 1999 May; 10(3):207-38. PubMed ID: 22346384 [TBL] [Abstract][Full Text] [Related]
17. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin]. Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686 [No Abstract] [Full Text] [Related]
18. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. Iannini PB Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736 [TBL] [Abstract][Full Text] [Related]
19. Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions. Borcherding SM; Stevens R; Nicholas RA; Corley CR; Self T J Fam Pract; 1996 Jan; 42(1):69-78. PubMed ID: 8537808 [TBL] [Abstract][Full Text] [Related]
20. [Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity]. Padeĭskaia EN Antibiot Khimioter; 2002; 47(1):26-35. PubMed ID: 12077937 [No Abstract] [Full Text] [Related] [Next] [New Search]